Chronic kidney disease trials in Serbia
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Belgrade, Kamenitz, Kragujevac, Niš, Novi Sad
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Belgrade, Kruševac, Sremska Mitrovica, Zaječar
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 3Taking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Belgrade, Kragujevac, Kruševac, Niš, Pančevo
- Age
- 18 years and over
- People
- 7,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - No phaseTaking peopleXeltis Hemodialysis Access (aXess) Conduit: aXess-E Study
- Where
- Belgrade
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- Xeltis
See details and how to joinNCT06329310 - Phase 3Taking peopleA Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- Where
- Belgrade, Kragujevac, Niš
- Age
- 18 years and over
- People
- 429 worldwide
- Run by
- Genexine, Inc.
See details and how to joinNCT06466785